Skip to main content

Genotropin News

FDA Medwatch Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death

[UPDATED 08/04/2011] FDA has determined that, at this time, the evidence regarding recombinant human growth hormone and increased risk of death is inconclusive. In its analysis of the SAGhE study, ...

FDA Medwatch Alert: Genotropin (somatropin [rDNA origin] for injection)

Pharmacia and FDA revised the CONTRAINDICATIONS and WARNINGS sections of the prescribing information for Genotropin, indicated for the long-term treatment of pediatric patients who have growth...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Genotropin patient information at Drugs.com